Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merge Healthcare Inc. -- Ignore unavailable to you. Want to Upgrade?

To: The Ox who wrote (85)	7/30/2014 11:13:19 AM
From: Sultan	Respond to of 134

Right.. I continue to hold my position..

To: The Ox who wrote (85)	7/30/2014 12:34:48 PM
From: Sultan	1 Recommendation Recommended By The Ox Respond to of 134

Merge Healthcare Incorporated's (MRGE) CEO Justin Dearborn on Q2 2014 Results - Earnings Call Transcript seekingalpha.com

To: The Ox who wrote (85)	8/12/2014 2:55:57 AM
From: Sultan	Respond to of 134

Why Merge Healthcare (MRGE) Could Be a Potential Winner By Zacks Equity Research August 7, 2014 6:53 AM It can be very difficult to find companies that are both flying under the radar, and still might have potential for gains. Many times, stocks are off investors’ radar screens for a reason, though there are some hidden gems that could be worth uncovering by those with a high risk tolerance. One way to find these underappreciated stocks is by looking at companies that haven’t seen their share prices move higher lately, but have observed analysts raising earnings estimates for their stock. This trend could signal that investors haven’t quite embraced the rising estimate story yet, but that the potential for a big move higher is definitely there. One such company that looks well positioned for a solid gain, but has been overlooked by investors lately, is Merge Healthcare Incorporated (MRGE). This Medical Info Systems stock has actually seen estimates rise over the past month for the current fiscal year by a significant amount. But that is not yet reflected in its price, as the stock gained only 2.6% over the same time frame. You should not be concerned about the price remaining muted going forward. This year’s expected earnings growth over the prior year is significant, which should ultimately translate into price appreciation. And if this isn’t enough, MRGE currently carries a Zacks Rank #2 (Buy) which further underscores the potential for its outperformance (See the performance of Zacks' portfolios and strategies here: About Zacks Performance). So if you are looking for a stock flying under-the-radar that is well-equipped to bounce down the road, make sure to consider Merge Healthcare. Solid estimate revisions and an impressive Zacks Rank suggest that better days may be ahead for MRGE and that now might be an interesting buying opportunity. finance.yahoo.com

To: The Ox who wrote (85)	10/29/2014 1:10:18 PM
From: Sultan	Respond to of 134

Merge Reports Third Quarter Financial Results finance.yahoo.com Merge Healthcare Incorporated's (MRGE) CEO Justin Dearborn on Q3 2014 Results - Earnings Call Transcript seekingalpha.com

To: The Ox who wrote (85)	11/25/2014 12:07:46 PM
From: Sultan	1 Recommendation Recommended By The Ox Read Replies (1) \| Respond to of 134

I consider this a meaningful news because this guy is the largest single share holder of MRGE.. The fact that he is back after couple of years tells me things are poised to move.. IMHO.. Change in Directors or Principal Officers Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers (d) Effective November 21, 2014, Michael W. Ferro, Jr. has rejoined Merge Healthcare Incorporated's (the "Company's") Board of Directors as its non-Executive Chairperson. The Company believes that its positive recent financial performance, coupled with a shifting competitive market landscape and changing macro-economic forces, have resulted in a variety of opportunities for both organic and strategic growth. Mr. Ferro, along with Merge's senior management and other outside Directors, will lead the Company's consideration of additional investments in its core software solutions and other value-enhancing alternatives in its key markets. In connection with Mr. Ferro's appointment to the Company's Board of Directors, the Company increased the size of the Board of Directors from 7 to 8 in accordance with Section 3.01 of the Company's bylaws. Dennis Brown, who served as the Chairperson of the Board of Directors from August 26, 2013 to November 21, 2014, will remain a member of the Board of Directors. Mr. Ferro, 48, previously served as a Director and Chairperson of the Company's Board of Directors from June 4, 2008 to August 26, 2013. Since May 2007, Mr. Ferro has served as chairman and chief executive officer of Merrick Ventures, LLC ("Merrick Ventures") a private investment firm. From June 1996 until October 2006, Mr. Ferro served as chief executive officer and chairman of the board of Click Commerce, Inc. Mr. Ferro is currently a member of the board of trustees of the Chicago Museum of Science and Industry, The Field Museum of Chicago, and Northwestern University. He also serves on the boards of directors of The Chicago Community Trust, Children's Memorial Hospital, The Joffrey Ballet of Chicago, the Lyric Opera of Chicago, Northwestern Memorial Foundation, Big Shoulders Fund, After School Matters, Wrapports, LLC, Economic Club of Chicago and the Renaissance School Fund. Mr. Ferro holds a B.A. from the University of Illinois. The section of the Company's definitive Proxy Statement, both dated and filed with the Securities and Exchange Commission on April 28, 2014 (File No. 001-33006), entitled "Transactions with Related Persons," at page 11 through 12, is incorporated by reference herein.